The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.
![]() ![]() | Boumahd, Y. (2024). Pharmacological inhibition of myoferlin induces a ferroptotic-like cell death and increases pancreatic cancer vulnerability to radiotherapy [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/323906 |
![]() ![]() | Boumahd, Y., Colin, G., Peiffer, R., Gullo, C., Agirman, F., Maloujahmoum, N., Coucke, P., Bellahcene, A., & Peulen, O. (04 July 2024). Modulation of radiosensitivity by myoferlin pharmacological targeting in human pancreatic cancer cell lines [Poster presentation]. IsCam 2024, Bruxelles, Belgium. |
![]() ![]() | Anania, S., Farnir, M., Peiffer, R., Boumahd, Y., Thiry, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (17 February 2024). Identification of myoferlin as a mitochondria-associated membranes component required for calcium signaling in PDAC cell lines. Cell Communication and Signaling, 22 (1), 133. doi:10.1186/s12964-024-01514-z ![]() |
![]() ![]() | Boumahd, Y., Colin, G., Peiffer, R., Gullo, C., Agirman, F., Maloujahmoum, N., Coucke, P., Bellahcene, A., & Peulen, O. (04 September 2023). Modulation of radiosensitivity by myoferlin pharmacological targeting in human pancreatic cancer cell lines [Poster presentation]. GIGA day 2023, Liège, Belgium. |
![]() ![]() | Peiffer, R., Boumahd, Y., Gullo, C., Agirman, F., Maloujahmoum, N., Masamune, A., Letellier Elisabeth, Bellahcene, A., & Peulen, O. (03 May 2023). Myoferlin, a new drug target in pancreatic CAFs, promotes desmoplasia and tumor aggressiveness [Poster presentation]. Gordon Research Conference - Pancreatic Diseases, Lucca, Italy. |
![]() ![]() | Dube, G., Tiamiou, A., Bizet, M., Boumahd, Y., Gasmi, I., Crake, R., Bellier, J., Nokin, M.-J., Calonne, E., Deplus, R., Wissocq, T., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (31 March 2023). Methylglyoxal: a novel upstream regulator of DNA methylation. Journal of Experimental and Clinical Cancer Research, 42 (1), 78. doi:10.1186/s13046-023-02637-w ![]() |
![]() ![]() | Peiffer, R., Boumahd, Y., Gullo, C., Crake, R., Letellier, E., Bellahcene, A., & Peulen, O. (22 December 2022). Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer. Cancers, 15 (1), 61. doi:10.3390/cancers15010061 ![]() |
![]() ![]() | Peiffer, R., Boumahd, Y., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Masamune Atsushi, Letellier Elisabeth, Bellahcene, A., & Peulen, O. (30 September 2022). The role of myoferlin in PDAC fibroblasts and desmoplasia [Poster presentation]. BACR - annual meeting 2022, Ghent, Belgium. |
![]() ![]() | Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (30 September 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Investigation of STAT3 involvement [Poster presentation]. BACR 2022, Gand, Belgium. |
![]() ![]() | Peiffer, R., Boumahd, Y., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Asamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (06 September 2022). The role of myoferlin in pancreatic cancer fibroblasts and desmoplasia [Poster presentation]. GIGA Day 2022, Liège, Belgium. |
![]() ![]() | Rademaker, G.* , Boumahd, Y.* , Peiffer, R., Anania, S., Wissocq, T., Liégeois, M., Luis, G., Sounni, N. E., Agirman, F., Maloujahmoum, N., De Tullio, P., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (July 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Redox Biology, 53, 102324. doi:10.1016/j.redox.2022.102324 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (22 June 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells [Poster presentation]. EACR 2022. ![]() |
![]() ![]() | Peiffer, R., Anania, S., Boumahd, Y., Agirman, F., Maloujahmoum, N., Masamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (June 2022). The oncoprotein myoferlin as potential new participant in myCAF activity in pancreatic cancer [Poster presentation]. EACR 2022, Sevilla, Spain. |
![]() ![]() | Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Gullo, C., Agirman, F., Maloujahmoum, N., Bellahcene, A., & Peulen, O. (2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Investigation on the involvement of STAT3 [Paper presentation]. GIGA Day 2022, Liège, Belgium. |
Gullo, C., Boumahd, Y., Peiffer, R., Anania, S., Agirman, F., Maloujahmoum, N., Thiry, M., Bellahcene, A., & Peulen, O. (2022). Myoferlin controls beta actin cytoskeleton integrity in pancreas cancer [Paper presentation]. GIGA Day 2022, Liège, Belgium. |
![]() ![]() | Boumahd, Y., Rademaker, G., Peiffer, R., Anania, S., Maloujahmoum, N., Agirman, F., Bellahcene, A., & Peulen, O. (14 December 2021). Myoferlin targeting primes ferroptosis in pancreatic cancer cells [Poster presentation]. GIGA cancer day. |
![]() ![]() | Peiffer, R., Anania, S., Boumahd, Y., Agirman, F., Maloujahmoum, N., Bossicard, Y., Masamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (December 2021). Deciphering the role of myoferlin in pancreatic stellate cells, key players in the pancreatic tumor microenvironment [Poster presentation]. GIGA-Cancer day 2021, Liège, Belgium. |
![]() ![]() | Anania, S., Boumahd, Y., Peiffer, R., Thiry, M., Hego, A., Maloujahmoum, N., Agirman, F., Bellahcene, A., & Peulen, O. (June 2021). Myoferlin, a promising therapeutic target in PDAC, is located in mitochondria-associated membranes [Poster presentation]. 27TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH. |
![]() ![]() | Peiffer, R., Anania, S., Boumahd, Y., Agirman, F., Maloujahmoum, N., Bossicard, Y., Masamune, A., Letellier, E., Bellahcene, A., & Peulen, O. (June 2021). New insights on the role of myoferlin in pancreatic stellate cells, the key orchestrators of pancreatic tumor microenvironment [Poster presentation]. EACR 2021. |